| KE 177 |
Increase, Mitochondrial dysfunction |
GO:0140053 |
mitochondrial gene expression |
describes |
medium |
SidraAdil |
2026-05-10 |
AOP 130, AOP 144, AOP 178, AOP 200, AOP 205, AOP 207, AOP 256, AOP 258, AOP 273, AOP 3, AOP 335, AOP 34, AOP 362, AOP 377, AOP 423, AOP 437, AOP 447, AOP 464, AOP 476, AOP 479, AOP 48, AOP 480, AOP 481, AOP 497, AOP 500, AOP 509, AOP 511, AOP 530, AOP 587, AOP 588, AOP 589, AOP 595, AOP 622, AOP 624, AOP 625, AOP 626, AOP 77, AOP 78, AOP 79, AOP 80, AOP 87, AOP 472 |
| KE 57 |
Proliferation, Cell proliferation in the absence of cytotoxicity |
GO:0051301 |
cell division |
describes |
medium |
SidraAdil |
2026-05-10 |
AOP 1 |
| KE 142 |
Hyperplasia, Hyperplasia |
GO:0014738 |
regulation of muscle hyperplasia |
describes |
high |
SidraAdil |
2026-05-10 |
AOP 1 |
| KE 334 |
Promotion, Hepatocelluar carcinoma |
GO:2000345 |
regulation of hepatocyte proliferation |
involves |
medium |
SidraAdil |
2026-05-10 |
AOP 1 |
| KE 214 |
Bile accumulation, Pathological condition |
GO:0015721 |
bile acid and bile salt transport |
describes |
medium |
SidraAdil |
2026-05-10 |
AOP 27 |
| KE 55 |
Increase, Cell injury/death |
GO:0043525 |
positive regulation of neuron apoptotic process |
describes |
high |
- |
2026-02-23 |
AOP 12, AOP 13, AOP 144, AOP 17, AOP 264, AOP 265, AOP 266, AOP 268, AOP 273, AOP 278, AOP 281, AOP 324, AOP 331, AOP 377, AOP 38, AOP 479, AOP 48, AOP 490, AOP 494, AOP 530, AOP 596, AOP 599, AOP 624, AOP 625, AOP 626, AOP 627, AOP 628, AOP 629 |
| KE 55 |
Increase, Cell injury/death |
GO:0006915 |
apoptotic process |
describes |
medium |
- |
2026-02-07 |
AOP 12, AOP 13, AOP 144, AOP 17, AOP 264, AOP 265, AOP 266, AOP 268, AOP 273, AOP 278, AOP 281, AOP 324, AOP 331, AOP 377, AOP 38, AOP 479, AOP 48, AOP 490, AOP 494, AOP 530, AOP 596, AOP 599, AOP 624, AOP 625, AOP 626, AOP 627, AOP 628, AOP 629 |